Leaders of the State Committee for Overseas Vietnamese Affairs attend the webinar. (Photo: quehuongonline.vn)

At the webinar, experts said Vietnam has been proactive in pandemic response, such as producing test kits or developing a vaccine against COVID-19. Nanocovax vaccine developed by Nanogen Pharmaceutical Biotechnology Joint Stock Company since last May is now ready for emergency licensing. In the first two phases of trials, the Nanocovax vaccine’s antibody index reached more than 90%.

Dr. Nguyen Huu Huan, Scientific Director of IGY Life Sciences Company and Professor of the University of Arizona, the US, said, “Phase 3 clinical trials are consistent with phase 1 and phase 2, meaning the protective effect is directly related to the ability to generate neutralizing antibodies. Even the degree of protection is proportional to the amount of neutralizing antibodies. Nanocovax produces quite good neutralizing antibodies, which can be said to be equivalent to Moderna. In terms of manufacturing capabilities, the company has many products in circulation that are manufactured using recombinant intravenous technology. These are products that require high quality and purity.”

Vietnam strives to have a domestically produced vaccine to be put into use later this year at the earliest.